USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	054174/0595			Pages:	4
		Recorded:	10/21/2020
Attorney Dkt #:	VARIOUS
Conveyance:	CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).

Total properties: 17

Patent #:	NONE	Issue Dt:		Application #:	15735812	Filing Dt:	12/12/2017
Publication #:	US20200041517	Pub Dt:	02/06/2020
Title:	COMPOSITIONS AND METHODS FOR TARGETING CANCER STEM CELLS

Patent #:	11028181	Issue Dt:	06/08/2021	Application #:	15775410	Filing Dt:	05/11/2018
Publication #:	US20180327509	Pub Dt:	11/15/2018
Title:	GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE

Patent #:	NONE	Issue Dt:		Application #:	16073349	Filing Dt:	07/27/2018
Publication #:	US20190031780	Pub Dt:	01/31/2019
Title:	COMPOSITIONS AND METHODS FOR TARGETING CANCER STEM CELLS

Patent #:	11299543	Issue Dt:	04/12/2022	Application #:	16306282	Filing Dt:	11/30/2018
Publication #:	US20190218293	Pub Dt:	07/18/2019
Title:	USE OF AN ANTI-PD-1 ANTIBODY IN COMBINATION WITH AN ANTI-CD30 ANTIBODY IN CANCER TREATMENT

Patent #:	NONE	Issue Dt:		Application #:	16319147	Filing Dt:	01/18/2019
Publication #:	US20200230254	Pub Dt:	07/23/2020
Title:	COMBINATION THERAPY USING A CD19-ADC AND RCHP

Patent #:	NONE	Issue Dt:		Application #:	16397331	Filing Dt:	04/29/2019
Publication #:	US20190381172	Pub Dt:	12/19/2019
Title:	STABLE FORMULATIONS FOR ANTI-CD19 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

Patent #:	11401330	Issue Dt:	08/02/2022	Application #:	16462075	Filing Dt:	05/17/2019
Publication #:	US20190276541	Pub Dt:	09/12/2019
Title:	GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE

Patent #:	NONE	Issue Dt:		Application #:	16462084	Filing Dt:	05/17/2019
Publication #:	US20200247902	Pub Dt:	08/06/2020
Title:	COMPOSITIONS AND METHODS FOR TREATING CANCER

Patent #:	11253609	Issue Dt:	02/22/2022	Application #:	16489569	Filing Dt:	08/28/2019
Publication #:	US20200000932	Pub Dt:	01/02/2020
Title:	GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE

Patent #:	10808039	Issue Dt:	10/20/2020	Application #:	16507839	Filing Dt:	07/10/2019
Publication #:	US20190338045	Pub Dt:	11/07/2019
Title:	MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS

Patent #:	NONE	Issue Dt:		Application #:	16588331	Filing Dt:	09/30/2019
Publication #:	US20200031938	Pub Dt:	01/30/2020
Title:	ANTIBODIES TO INTEGRIN AVB6 AND USE OF SAME TO TREAT CANCER

Patent #:	NONE	Issue Dt:		Application #:	16742434	Filing Dt:	01/14/2020
Publication #:	US20200276306	Pub Dt:	09/03/2020
Title:	Glycan-Interacting Compounds and Methods of Use

Patent #:	RE49435	Issue Dt:	02/28/2023	Application #:	16776188	Filing Dt:	01/29/2020
Title:	GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE

Patent #:	NONE	Issue Dt:		Application #:	16791174	Filing Dt:	02/14/2020
Publication #:	US20210011021	Pub Dt:	01/14/2021
Title:	Glycan-Interacting Compounds and Methods of Use

Patent #:	NONE	Issue Dt:		Application #:	16850353	Filing Dt:	04/16/2020
Publication #:	US20210017213	Pub Dt:	01/21/2021
Title:	Glycan Analysis and Profiling

Patent #:	NONE	Issue Dt:		Application #:	16933349	Filing Dt:	07/20/2020
Publication #:	US20200347149	Pub Dt:	11/05/2020
Title:	MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS

Patent #:	NONE	Issue Dt:		Application #:	17061998	Filing Dt:	10/02/2020
Publication #:	US20210101982	Pub Dt:	04/08/2021
Title:	ANTI-PD-L1 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

Assignor

Exec Dt:

10/06/2020

Assignee

21823 30TH DRIVE SE

BOTHELL, WASHINGTON 98021

Correspondence name and address
	SEAGEN INC.
	21823 30TH DRIVE SE
	BOTHELL, WA 98021

Search Results as of: 09/25/2024 12:09 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6